Intranasal Ketorolac Tromethamine (SPRIX) as a Short Term Pain Management of Post-Vasectomy Pain
Status:
Unknown status
Trial end date:
2013-12-01
Target enrollment:
Participant gender:
Summary
To evaluate the efficacy, tolerability and safety of intranasal ketorolac tromethamine
(SPRIX) as an option for pain management in post vasectomy patients.